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Abstract.  There is strong evidence to indicate that 
proteins of the synaptobrevin family play a key role in 
exocytosis. Synaptobrevin 1 and 2 are expressed at 
high concentration in brain where they are localized 
on synaptic vesicles. Cellubrevin, a very similar pro- 
tein,  has a  widespread tissue distribution and in 
fibroblasts is localized on endosome-derived, transfer- 
rin receptor-positive vesicles. Since brain cellubrevin 
is not detectable in synaptic vesicles, we investigated 
whether cellubrevin and the synaptobrevins are 
differentially targeted when co-expressed in the same 
cell. We report that in the nervous system cellubrevin 
is expressed at significant levels only by glia and vas- 
cular cells.  However, cellubrevin is coexpressed with 
the two synaptobrevins in PC12 cells, a neuroendo- 
crine cell line which contains  synaptic vesicle-like 
microvesicles. In PC12 cells, cellubrevin has a distri- 
bution very similar to that of synaptobrevin 1 and 2. 
The three proteins are targeted to neurites which ex- 
clude the transferrin  receptor and are enriched in 
synaptic-like microvesicles and dense-core granules. 
They are recovered in the synaptic-like microvesicle 
peak of glycerol velocity gradients,  have a  similar dis- 
tribution in isopycnic fractionation and are coprecipi- 
tated by anti-synaptobrevin 2 immunobeads.  Finally, 
cellubrevin, like the synaptobrevins, interact with the 
neuronal t-SNAREs syntaxin  1 and SNAP-25. These 
results suggest that cellubrevin and the synaptobrevins 
have similar function and do not play a  specialized 
role in constitutive and regulated exocytosis, respec- 
tively. 
convergence  of studies carded out in a variety of ex- 
perimental systems has demonstrated that small pro- 
teins present at the cytoplasmic surfaces of transport 
vesicles and of target membranes play a key role in mem- 
brane docking and fusion (S611ner et al.,  1993a,b; Bennett 
and Scheller,  1993; Ferro-Novick and Jahn,  1994).  These 
proteins,  called v- and t-SNAREs respectively, because they 
act as SNAP receptors, have cytoplasmic domains with short 
membrane anchors (S611ner et al., 1993a,b).  Synaptobrevin 
1 and 2 (VAMP1 and 2) are v-SNAREs expressed at high 
concentrations  in neurons where they are concentrated  on 
synaptic vesicles (Trimble et al., 1988, 1990; Baumert et al., 
1989). Their selective cleavage by the light chains of tetanus 
toxin and of botulinum toxins  B, D, and F  is responsible 
for the potent block of neurotransmitter  release produced 
by these toxins (Schiavo et al.,  1992,  1993;  Yamasaki et 
al.,  1994). 
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A protein which shares  a high degree of similarity  with 
synaptobrevin  1 and 2,  referred  to as cellubrevin,  is  ex- 
pressed in a wide variety of tissues (McMahon et al., 1993). 
In fibroblasts,  this protein was found to be closely colocal- 
ized with vesicles which recycle transferrin  (Tf)  ~ receptor 
(McMahon et al., 1993; GaUi et al., 1994). Cellubrevin,  like 
the two synaptobrevins,  is a substrate  for the proteolytic ac- 
tion of tetanus  toxin (McMahon et al.,  1993; Galli  et al., 
1994;  Yamasaki et  al.,  1994),  and  its  cleavage  in  SLO- 
permeabilized cells impairs  the constitutive  exocytosis of 
endosome-derived vesicles  (Galli et al.,  1994). 
The identification of families of v- and t-SNARES (Elfer- 
ink et al., 1989; Bennett and Scheller,  1993; Bennett et al., 
1993; Chin et al., 1993; McMahon et al., 1993; DiAntonio 
et al.,  1993) has raised the possibility that the multiplicity 
of these proteins  may be responsible for conferring  spe- 
cificity  to exocytosis of distinct  vesicular carders.  In any 
given cell, the presence of distinct  v-SNAREs on different 
types of secretory vesicles may play a role in defining tern- 
1. Abbreviations used in this paper: Tel'x, tetanus toxin; TeTx-LC,  tetanus 
toxin light chain; Tf, transferrin; SL-O,  streptolysin-O. 
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ously shown that in neurons the "IT receptor is excluded from 
axons and synaptic vesicles, and is restricted to somato- 
dendritic regions (Cameron et al.,  1991; Mundigl et al., 
1993). It was therefore of interest to determine whether cel- 
lubrevin is expressed in cells which contain synaptic vesicles 
and whether it is targeted to these organelles or is restricted 
to Tf receptor containing vesicles. 
Although cellubrevin is expressed in the nervous system 
(McMahon et al.,  1993),  we report here that in brain it is 
localized primarily in supportive ceils (glial,  endothelial, 
and ependymal cells). However, cellubrevin is expressed to- 
gether with synaptobrevin 1 and 2 in neuroendocrine PC12 
cells,  which contain synaptic-like microvesicles.  In these 
cells, ceUubrevin is colocalized with synaptobrevin 1 and 2 
and interacts with the same neuronal t-SNAREs, syntaxin 1, 
and SNAP-25.  These findings speak against a  specialized 
role of cellubrevin for constitutive secretion and suggest that 
the three v-SNAREs have similar function. 
Materials and Methods 
Materials 
[12sI]Protein  A (8.8 #Ci/ttg) was purchased from NEN (Wilmington, DE), 
[3H]norepinephrine (238 #Ci/#g) and ECL detection reagents were from 
Amersham Corp. (Adington Heights, IL), reduced streptolysin-O (SL-O) 
from Murex  Diagnostics (Norcross,  GA),  ATP  (magnesium  salt)  from 
Sigma Chem.  Co.  (St.  Louis, MO),  and human diferric Tf from GIBCO 
BRL (Galthershurg, MD). Tissue culture reagents were from GIBCO BRL. 
The recombinant light chain of tetanus toxin (TeTx-LC) was a kind gift from 
Dr. H. Niemann (Bundesforschungsanstalt fOr Viruskranldaeiten der Tiere, 
"l~ibingen,  Germany).  A  stock solution of TeTx-LC was prepared as de- 
scribed by McMahon et al.  (1993) at a concentration of 13 t~M in buffer 
T  (10 mM Pipes,  150 mM K-glutamate,  pH 7.2). 
Antibodies 
Antibodies specific for synaptophysin (MC1),  synaptobrevin 2  (MC 23), 
and SNAP-25 (MC21) were generated in rabbits by injecting synthetic pep- 
tide corresponding to the following amino acid sequences of the three pro- 
teins flanked by an additional cysteine (shown in italics): amino acids 258- 
274 of synaptophysin, GGYQPDYGQPAS~C,  amino acids  1-16 of 
synaptobrevin  2,  MSATAATVPPAAPAGEC,  amino  acids  195-206  of 
SNAP-25A,  CANQRATKMLGSG.  The additional cysteine was used for 
conjugation to keyhole limpet hemocyanin (Calbiochem-Behring Corp., La 
Jolla, CA). The sera were affinity purified using the peptide conjugated to 
EAH Sepharose (Pharmacia, Uppsala, Sweden). Rabbit antibodies specific 
for  synaptobrevin  1  (MC9),  cellubrevin (MCI6),  and  synaptotagmin  1 
(8907) were described in earlier studies (Galli et al.,  1994; Mundigl et al., 
1993). The specificity of the antibodies for synaptobrevin 1 and 2 and cel- 
lubrevin was confirmed by Western blotting of these proteins expressed as 
recombinant fusion proteins and in rat brain and PC12 cell extracts. In all 
cases the three antibodies recognized selectively bands with the expected 
differences in electrophoretic mobility in Schagger gels (see below). The 
following antibodies were generous gifts:  monoclonal antibodies against 
synaptobrevin 2  (CI 69.1)  (Edelmann et al.,  1994) and synaptotagmin  1 
(C141.1) (Matteoli et al., 1992) from Dr. R. Jahn (Yale University, New Ha- 
ven, CT),  monoclonal antibody against syntaxin 1 (HPC-I) from Dr.  C. 
Barnstable (Yale University), monoclonal antibody against the 30-kD ADP/ 
ATP translocator of the inner mitochondrial membrane from Dr. W. Neu- 
pert (University of Munich, Munich, Germany), rabbit sera directed against 
secretogranin 1 and 2 (Rosa et ai.,  1985) from Dr. P. Rosa (Milano, Italy) 
and monoclonal antibodies anti-human Tf receptor (No. H68.4) from Dr. 
I. Trowbridge (Salk Institute, La Jolla, CA). Indocarbocyanine (Cy3)- and 
fluorescein  (DTAF)-conjugated  goat  anti-rabbit and  -mouse  IgGs were 
from Jackson lmmuno-Research Labs (West Grove, PA). Nonimmune rab- 
bit IgGs and rabbit anti-mouse IgGs were from Cappel (Cochranville, PA), 
anti-Tf monoclonal antibodies were from Accurate Chemical and Scientific 
Corp. (Westbury, NY), anti-synaptophysin monoclonal antibodies (SVP38) 
from Sigma Chem. Co. 
Hippocampai Cell Cultures 
Neurons were grown on glass coverslips as described by Banker and Cownn 
(1977) and Bartlett and Banker (1984). Briefly, hippocampi from 18-d-old 
fetal rats were dissociated by treatment with trypsin (0.25%  for 15 min at 
37°C),  followed by trituration with a  fire-polished Pasteur pipette.  Dis- 
sociated cells were plated on poly-L-lysine-treated glass coverslips in MEM 
with 10% horse serum at densities ranging from 1,01)(O4,000  cells/cm  2. 
After 3 h, cortical giial cells (Booher and Sensenbrenner, 1972) were plated 
at a density of 1,500 celis/cm  2 on top of the neurons. After attachment of 
the  glial  cells,  coverslips  were  then transferred  to dishes  containing a 
monolayer of cortical giial cells (Boober and Sensenbrenner, 1972), so that 
they were suspended over the giial cells but not in contact with them (Boo- 
her and Sensenbrenner,  1972).  Cells were maintained in MEM  without 
sera, supplemented with 1% HL1  (Ventrex, Portland, ME), 2 mM gluta- 
mine and 1 mg/ml BSA (neuronal medium) and used for immunofluores- 
cence after 4-5 d  in vitro. 
PC12 Cell Cultures 
PC12 cells (Greene and Tischler, 1976) were grown as monolayer cultures 
on collagen-coated tissue culture dishes in DME supplemented with 10% 
fetal bovine serum, 5% horse serum, 100 U/ml penicillin, 100 #g/ml strep- 
tomycin at 37°C in 7.5% CO2.  For NGF differentiation, PC12 cells were 
first primed for 2 wk with 50 ng/ml NGF 2.5S (from rat submaxillary gland, 
grade II; Boehringer-Mannheim Biocbemieals, Indianapolis, IN) in DME 
supplemented with 1% horse serum in 7.5% CO2. Cells were then squirted 
from the dish with fresh media and pelleted by centrifugation for 5 rain at 
250 g. To reduce the number of cell aggregates, pellets were resuspended 
in 0.25% trypsin-EDTA (Sigma Chem. Co.) and incubated for 15 rain at 
37°C.  They  were  then  pelleted  and  resuspended  in  serum-containing 
medium  (see above),  dissociated with a  fire polished Pasteur pipet and 
plated on laminin-coated coverslips at a density of 7,500-15,000 cellgtcm  2. 
After 2-4 h of incubation at 37"C, the coverslips were inverted and placed 
over a bed of giial cells as previously described for hippocampai neurons 
(Goslin and Banker, 1990). The cells were maintained in neuronal medium, 
in 5 % CO2, with no NGF added,  and used after 3-5 d  in vitro. 
Immunofluorescence 
Rat brain fixation, preparation of frozen sections and irnmunofluorescence 
was performed as previously described (De Camilli et al.,  1983; Takei et 
al., 1992). PC12 cells were fixed with 4 % formaldehyde in phosphate buffer 
containing 4%  sucrose and processed for double immunofluorescence as 
previously described (Cameron et al., 1991; Mundigl et al., 1993). In some 
cases, prior to fixation cells were incubated for 1 h at 370C in buffer K (20 
mM  Hepes,  128  mM  NaCI,  3  mM  KC1,  1  mM  Na2HPO4,  1.2  mM 
MgSO4, 2.7 mM CaCI2, and  11 mM glucose,  pH 7.4, with NaOH) con- 
taining 50 #g/ml human diferric "If. They were then briefly washed with 
cold buffer and fixed. 
Glycerol and Sucrose Gradients 
Velocity centrifugation on glycerol  density  gradients of PC12  cells and 
RINm5  cells homogenates  (Gazdar et al.,  1980)  was performed as de- 
scribed by Cameron et al. (1991).  The synaptobrevin and cellubrevin con- 
tent of the various fractions was analyzed by immunoprecipitation followed 
by Western blotting. Sucrose equilibrium density gradient centrifugation of 
post nuclear supernatants of PC12 cells and bovine chromaffin cells was per- 
formed as described by Navone et al.  (1989). 
lmmunobead Isolation of Organelles 
Monoclonal antibodies C169.1 or SVP38 were covalently coupled to Euper- 
git CIZ immanobeads (1-t~m mean diana; Roehm Pharma, Darmstadt, Ger- 
many) as described (Burger et al.,  1989). PC12 cells were washed in buffer 
K, pelleted and resuspended at a density of 15 x  106 cells/ml in homogeni- 
zation buffer (0.25 M sucrose, 4.0 mM Hepes, pH 7.2,  1 mM MgCl2, 0.4 
mM PMSE  1 mM benzamidine,  1 #g/rnl pepstatin,  1 #g/ml antipain,  1 
/zg/ml leupeptin,  and  1 #g/ml aprotinin). The cells were then passed 20 
times  through  a  ball  bearing  cell  cracker  (Bernie-tech  Engineering, 
Saratoga, CA) with a 0.0006 in. clearance and the lysate was centrifuged 
for 20 min at 10,000 g.  Supernatants (containing ",,2 mg/ml protein) were 
incubated with anti-synaptophysin or anti-synaptobrevin 2 beads, respec- 
tively, for 4 h at 4°C under rotation. A ratio of immunobeads to cell extract 
was used sufficient to deplete all synaptobrevin 2-positive organelles from 
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washed three times with homogenization buffer. 
Electron Microscopy of  lmmunobead 
Adsorbed Organelles 
A PC12 cell lysate was obtained as described above and centrifuged at 676 
g  for 15 rain. Supernatants were incubated with anti-synaptobrevin 2 or 
control mouse IgGs immunobeads for 3 h at 40C under rotation to allow 
adsorption of synaptobrevin 2 containing organelles to the immunobeads. 
The samples were fixed with 3 % paraformaldehyde, 2 % glutaraldehyde, 
0.25 M sucrose in 5 mM Hepes-KOH, pH 7.4, for 1 h, centrifuged for 3 min 
at 13,800 g.  The beads were resuspended in 0.12 M Na-phosphate buffer 
and embedded in 1% agarose. The agarose blocks were postfixed with 1% 
OsO4 in 0.1 M Cacodylate, pH 7.4,  dehydrated, embedded in EPON812, 
and cut in thin sections (30 am). The samples were analyzed on a Philips 
CM10 microscope. 
Immunoprecipitation of the SNARE Complexes 
PC12 cells were washed once with buffer K. They were then resuspended 
in solubilization buffer (50 mM Tris-HCl, pH 8,  150 mM NaC1,  l0 mM 
EDTA, 1 mM PMSE 1 mM benzamidine, 1 pg/ml pepstatin, 1/~g/ml an- 
tipain,  1 /zg/ml  leupeptin,  1 tzg/ml  aprotinin) at a  concentration of 1-2 
mg/ml. Triton X-100 was then added at a final concentration of 1% and the 
resulting cell extract was incubated for one hour at 4-60C under rotation 
and subsequently centrifuged at 200,000 g for 15 min. The supernatant was 
incubated overnight at 4-6°C  under rotation,  with protein G  sepharose 
beads (for mouse antibodies) or protein A (for rabbit antibodies) (Pharma- 
cia, Piscataway,  NJ) precoated with the following antibodies: monoclonal 
anti-synaptobrevin 2  (Cl  69.1),  monoclonal  anti-syntaxin  1  (HPC-1), 
mouse control IgGs, rabbit serum directed against SNAP-25 (MC21), con- 
trol rabbit IgGs. The beads were then pelleted for 1 rain at 14,000  g and 
washed three times with solubilization buffer containing 1% Triton X-100. 
Finally, the beads were resuspended in gel sample buffer and boiled for 
5 rain. 
Norepinephrine Release  from 
Streptolysin-O-perforated Cells 
Streptolysin-O (SL-O) was used to perforate cells as previously described 
(Ahnert-Hilger et  al.,  1989;  Miller and  Moore,  1992).  Approximately 
40 x  106 PC12 cells were resuspended in RPMI media supplemented with 
1 mM ascorbic acid at a density of 2  x  106 cells/ml and were incubated 
with 2 #Ci/ml of laH]norepinephrine (NE) for 2 h at 37°C and 7.5%  CO2. 
At the end of the incubation, cells were washed with 1 ml of ice-cold buffer 
K  (see above) by  sedimentation and  resuspension using  an  Eppendorf 
5154C microcentrifuge. The cells were then washed two times with 1 ml 
of ice-cold buffer A (20 mM Hepes, 110 mM NaCI, 5.4 mM KCI, 0.9 mM 
Na2HPO4,  10 mM MgC12, 2 mM CaCI2,  11  mM glucose, pH 7.4, with 
NaOH),  resuspended in  buffer A  to  give a  final  concentration of  I(P 
cells/tzl  and mixed with an equal volume of buffer A containing SL-O (0.3 
IU/ml fnal concentration). After incubation in an ice-water bath for 10 rain, 
excess SL-O was removed by centrifugation and one wash with 1 ml of 
buffer B (20 mM Hepes, 100 mM K-glutamate, 40 mM KCI, 5 mM EGTA, 
pH 7.2, with KOH). The cell suspension was split in two and both samples 
were pelleted. One sample was resuspended with 2 ml of  buffer B containing 
2  mM Mg-ATP and  1 mM free Mg  z+  (added as MgCI2)  with no Ca  2+ 
added, the other sample with 2 ml of the same medium but with 100/zM 
free Ca2+(added  as CaCI2).  The concentration of free Mg  2+ and Ca  2+ were 
calculated using the software by Ffhr and Warehol (Ulm, FRG) (F6hr et 
al.,  1993).  Submicromolar concentrations of free Ca  2+ were used to in- 
duce release because at these low concentrations Ca  2+ triggers release only 
from permeabilized cells (Wilson and Kirshner,  1983).  Each of the two 
samples was further split in two, and the light chain of tetanus toxin (TeTx- 
LC) was added to one of the two halves at the final concentration of 300 
nM. 100-tzl aliquots of  each of  the four cell suspensions were then incubated 
at 37°C for 0, 5,  15, and 25 rain after which supernatants and pellets were 
collected separately. As previously reported, the SL-O-indueed formation 
of cell pores occurs as soon as the cells are shifted to 37°C (Ahnert-Hilger 
et al., 1989).  Triplicate samples were prepared for each time point. Pellets 
were immediately resuspended in 100/~1 of SDS sample buffer and subse- 
quently processed for SDS-PAGE and Western blotting. The amounts of 
[3H]NE  in the supernatants and corresponding pellets were measured in a 
/3-counter (LKB, Bromma, Sweden). The amount of [3H]NE  recovered in 
the supernatant at the 0 time point was defined as background and therefore 
subtracted from each individual release value obtained at later incubation 
times. [3H]NE secretion (supernatant) was expressed as the percent of the 
total amount of [3H]NE present in each sample (supernatant plus pellet). 
Each experiment was repeated at least three times, and a single representa- 
tive experiment is shown in each figure. Values are reported as the mean :t: 
SD of three determinations. 
In pilot experiments, the effectiveness  of the permeabilization procedure 
for cells in suspension was assessed by incubating SL-O treated cells with 
propidium iodide (1/~g/ml) or fluorescein labeled phalloidin (50 nM) fol- 
lowed by flow cytometry analysis using a FACSTARplus cell sorter (Becton 
Dickinson, San Jose, CA) (excitation at 488 nm and emission at 630 and 
530 rim, respectively). Over 90% of the cells were found to be perforated. 
Western Blot Analysis 
Homogenates of tissues and cells were prepared in 10 mM Hepes, pH 7.4, 
150 mM NaCI, 0.1 mM MgC12, 1 mM EGTA plus protease inhibitors (1 
/zg/ml  each of leupeptin, aprotinin, pepstatin, and antipain and 0.4 mM 
PMSF).  Protein concentrations were determined using the procedure of 
Petersen (1977).  SDS-polyacrylamide gel electrophoresis was performed 
according to Schagger and von Jagow (1987),  a procedure which maximizes 
separation of low molecular weight proteins.  Immunoblotting was per- 
formed as described by Towbin et al. (1979) using either ECL or [125I] pro- 
tein A as the detection system. 
Results 
Fig.  1 shows that synaptobrevin  1 and 2,  as well as cel- 
lubrevin, as detected by rabbit anti-peptide antibodies specific 
for each of the three proteins, are expressed in brain. How- 
ever, while synaptobrevin 1 and 2 were enriched in a synaptic 
vesicle preparation, cellubrevin, which is present at low con- 
centrations in brain, was not detectable in the same synaptic 
vesicle fraction. To demonstrate whether this result is ex- 
plained by differential targeting of cellubrevin and synap- 
tobrevin 1 and 2 in neurons, we investigated the localization 
of the three proteins by immunofluorescence on frozen brain 
sections and in primary cultures of  brain cells. These experi- 
ments demonstrated that cellubrevin immunoreactivity was 
concentrated in glial cells and other supportive cells of the 
nervous system, but was not detectable in neurons. Examples 
of the differential distribution of the synaptobrevins and cel- 
lubrevin are shown in Figs. 2 and 3. Synaptobrevin 1 and 2 
immunoreactivities are highly concentrated in nerve termi- 
nals of the molecular layer and the granule cell layer, where 
they are colocalized with synaptophysin (Fig. 2, a-d). Cel- 
lubrevin, in contrast, is concentrated in non-neuronal cells 
including endothelial and ependymal cells (see Figs. 2, e and 
f  and 3,  a-d).  In primary  culture of brain cells,  synap- 
tobrevin  2  is  highly  concentrated  in  neurons  while  cel- 
lubrevin immunoreactivity is restricted primarily to glial 
cells (Fig. 3, e and f). In glial cells, cellubrevin was found 
to be closely colocalized with internalized Tf in the region 
of  the  Golgi  complex  and  in  vesicles  throughout  the 
cytoplasm (not shown) as described previously for CHO 
cells (Galli et al.,  1994). 
To determine if cellubrevin, like synaptobrevin 1 and 2, 
contains a signal which can target it to synaptic vesicles, it 
was important to identify a cell type which: (a) expresses all 
three  proteins;  and  (b)  contains  synaptic vesicle-like or- 
ganelles.  PC12  cells were found to have these properties. 
The presence of organelles which are structurally and bio- 
chemically related to synaptic vesicles of neurons referred to 
as synaptic-like microvesicles, and which exclude Tf recep- 
tors, is well documented in these cells (Navone et al., 1986; 
Wiedenmann et al.,  1988;  Cameron et al.,  1991; Linstedt 
and Kelly, 1991). As shown in Fig. 4, the synaptobrevins and 
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lubrevin, in synaptic vesicles of rat brain. Proteins in brain homog- 
enate (Brain,  100/~g/lane)  and purified synaptic vesicles (SE, 50 
/~g/lane) were separated by SDS-PAGE  and probed by Western blot- 
ting for the presence  of synaptobrevin  1 (SB1), synaptobrevin 2 
(SB2), and cellubrevin (CB). 
cellubrevin are expressed in PC12 cells. Synaptobrevin 1 and 
2  are present at a  much lower concentration in PC12 cells 
than in brain, while ceUubrevin is present at a much higher 
concentration in PC12 ceils (Fig.  4). 
The distribution of the three proteins was investigated by 
immunofluorescence in PC12 cells which had been primed 
with NGF and then cultured, with no NGF added, on cover- 
slips inverted over a monolayer of cortical astrocytes as de- 
scribed for hippocampal neurons (Goslin and Banker, 1990). 
Coculture with glial cells was found to be particularly effec- 
tive in promoting neurite outgrowth (Fig. 5). In PC12 cells, 
not only synaptobrevin 1 and 2 immunoreactivities, but also 
cellubrevin  immunoreactivity,  were  concentrated  in  neu- 
rites, which are enriched in synaptic-like microvesicles and 
dense-core secretory granules (Fig. 5). In addition, punctate 
immunoreactivity for all three proteins was present in the 
perikaryal region where a particularly high concentration of 
the proteins was localized in the area occupied by the Golgi 
complex. As shown by double immunofluorescence, the dis- 
tribution of each of the three proteins was found to be very 
similar to the distribution of synaptophysin, a synaptic vesi- 
cle protein which in PC12 cells is concentrated in the mem- 
branes of synaptic-like microvesicles and endosomes (Came- 
ron et al.,  1991)  (Fig.  5). 
To  determine  whether  cellubrevin  immunoreactivity  in 
neurites was due to the concentration of Tf-containing vesi- 
cles in these processes, rather than to the localization of cel- 
lubrevin in synaptic-like microvesicles and possibly dense- 
core secretory granules, PC12 cells were double labeled for 
synaptobrevin and Tf following a  1-h incubation with iron- 
saturated Tf. This procedure allows steady-state labeling of 
all "IT receptor-containing compartments (Cameron et al., 
1991).  As  shown  in  Fig.  6,  Tf immunoreactivity was  re- 
stricted to cell bodies and was virtually absent from neurites 
Figure 2. Differential localization of  the two synaptobrevins and of cellubrevin in rat cerebellum. Frozen sections were processed by double 
immunofluorescence for each of the three proteins (top) and for synaptophysin (bottom). The distribution of synaptobrevin  I (SBI) and 
synaptobrevin 2 (SB2) immunoreactivity  is very similar to the distribution  of synaptophysin immunoreactivity  (P38). Cellubrevin im- 
munoreactivity  (CB) is primarily  localized in endothelial cells and in glial cells of both gray and white matter. Bar,  100/zm. 
The Journal of Cell Biology, Volume 129, 1995  222 Figure 3. Differential localization of synaptobrevin 2 and cellubrevin in frozen sections of rat brain and primary culture of rat brain cells. 
(/bp) Double immunofluorescence of brain stem (a and b) and cerebral  cortex (c and d) for synaptobrevin 2 (SB2)  and for cellubrevin 
(CB). Synaptobrevin 2 immunoreactivity has the typical nerve terminal pattern while cellubrevin is primarily localized in supportive cells 
(b) and cells of the choroid plexus (d). (Bottom)  Double immunofluorescence of a coculture of neurons and astrocytes for synaptobrevin 
2 (SB2) and cellubrevin (CB).  Synaptobrevin 2 immunoreactivity is restricted to the neuron and cellubrevin to the astrocytes. Bars: (A) 
20 ~tm; (B) 25 #m. 
where both the synaptobrevins and cellubrevin were local- 
ized. However, it was not possible to discriminate from the 
fluorescent images whether cellubrevin was colocalized with 
synaptobrevin on  the  same  organdies  or  whether  it  was 
localized on a separate population of endosomal membranes. 
A  unique property of synaptic-like microvesicles is their 
migration in  glycerol velocity gradients as a  peak distinct 
from that of endosomal membranes (Cameron et at.,  1991; 
Linstedt and Kelly, 1991).  Therefore, a low speed superna- 
tant from an undifferentiated PC12 cell homogenate was ana- 
lyzed by this  method.  Gradient  fractions  were probed by 
Western blotting for their cellubrevin, synaptobrevin 2, syn- 
aptophysin and  Tf receptor content  (Fig.  7).  Early endo- 
somes, as indicated  by the distribution  of the Tf receptor, 
were present only in the fractions at the bottom of the gra- 
dient which also contains a  variety of other organdies in- 
cluding plasma membrane and dense-core secretory gran- 
ules  (Fig.  7,  fractions  10-12)  (Cameron et al.,  1991).  As 
described previously, synaptophysin migrated as two well- 
defined  peaks:  an  endosomal  peak  and  a  slower  moving 
peak, corresponding to synaptic-like microvesicles (Fig. 7, 
peak in fraction 5) (Cameron et al.,  1991).  A migration in 
two peaks, similar to that of synaptophysin but different from 
that of the Tf receptor, was observed for both synaptobrevin 
Figure  4.  Comparison of the expression of synaptobrevin 1 and 2 
and of  cellubrevin in brain and PC12 cells. Proteins in homogenates 
of  rat brain (25/zg/lane) and PC12 cells (50/~g/lane) were separated 
by SDS-PAGE and probed by Western blotting for the presence of 
synaptobrevin 1 (SB1),  synaptobrevin 2 (SB2) and cellubrevin (CB). 
Chilcote et al. Cellubrevin and Synaptobrevins in PC12 Cells  223 Figure 5. Concentration and colocalization  of synaptobrevin 1 and 2 and cellubrevin with synaptophysin  in neurites of NGF-ditferentiated 
PC12 cells. Double immunofluorescence  for each of the three proteins (SB1, SB2, and CB) (left) and for synaptophysin  (P38) (right).  Bar, 
50 t~m. 
2 and cellubrevin (Fig. 7). A similar sedimentation pattern 
in glycerol velocity gradients was observed for cellubrevin 
from low-speed postnuclear supernatants of RINm5 ceils, a 
pancreatic  endocrine  cell  line  (data  not  shown).  These 
results demonstrate the presence of cellubrevin in synaptic- 
like microvesicles in both PC12 and RINrn5 cells. 
The membrane distribution of synaptobrevin 1 and 2 and 
ceUubrevin,  was also compared in isopycnic centrifugation 
on sucrose density gradients (Fig.  8).  This procedure al- 
lows separation of dense-core secretory granules from the 
peak fractions of synaptic-like microvesicles and other light 
membranes (such as endosomes and plasmalemma) (Came- 
ron et al., 1991; Reetz et al., 1991). The migration in the gra- 
dient of synaptic-like microvesicles and endosomes was indi- 
cated by the presence of synaptophysin, and the migration 
of dense core granules by the presence of secretogranin 1, 
a secretory peptide (Rosa et al.,  1985) (Fig. 8).  The dense 
fractions of the gradient containing the granules were also 
highly enriched in synaptotagmin (Fig. 8) as previously ob- 
served (Walch-Solimena et al.,  1993).  The migrations of 
The Journal of Cell Biology, Volume  129, 1995  224 Figure 6. Concentration of synaptobrevins and cellubrevin, but not pre-internalized human Tf, in the neurites of NGF-differentiated PC12 
cells. PC12 cells were incubated with human Tf (50 #g/ml) prior to fixation. They were then stained by double immunofluorescence for 
internalized Tf (Tf) and for synaptobrevin 1 (SB1), synaptobrevin 2 (SB2) and cellubrevin (CB).  Bar, 50/~m. Figure  7. Distribution of endosomal and synaptic vesicle proteins 
from a  low  speed  supernatant  of PCl2  cell  homogenate on a 
glycerol velocity gradient.  The low-speed supernatant was cen- 
trifuged on a 5-25% glycerol gradient with a 50% sucrose cushion 
at the bottom of the gradient. Equal volumes of each fraction (Tf 
Receptor, synaptophysin),  or immunoprecipitates of equal volumes 
(synaptobrevin  2, cellubrevin),  were analyzed by SDS-PAGE and 
Western blotting. The fractions are numbered starting from the top 
of the gradient. Synaptobrevin 2 and cellubrevin, but not "If recep- 
tor,  are present in the synaptic-like microvesicle peak (fractions 
4-6),  identified by the presence of synaptophysin, 
synaptobrevin 1 and 2 and of  ceUubrevin in the gradient were 
very similar, with the bulk of the three proteins being recov- 
ered in light fractions. Their migration was in turn similar 
to that of synaptophysin. However, a light trail of all these 
proteins overlapped with the dense-core granule containing 
fractions (Fig.  8). 
Finally, to assess  whether the three v-SNAREs are co- 
localized on the  same  vesicles,  we  carried out organelle 
immunoisolation experiments. A PC12 cell extract was in- 
cubated  with  anti-synaptobrevin 2  immunobeads  and  the 
presence of synaptobrevin  1  and  cellubrevin on  the  im- 
munoisolated organelles was assessed by Western blotting. 
Immunoisolation experiments with anti-synaptophysin im- 
munobeads and non-immune mouse IgGs were carried out 
as controls. As shown in Fig. 9, the bulk of synaptobrevin 
2  was recovered in the pellet fraction (P) using both anti- 
synaptophysin and anti-synaptobrevin 2  immunobeads.  A 
similar  enrichment  in  the  pellets  was  observed  for  syn- 
aptobrevin 1 and cellubrevin and for other proteins of syn- 
aptic-like microvesicles, secretory granules and endosomes 
(synaptophysin, synaptotagmin 1, secretogranin 2 and trans- 
ferrin receptor). The property of anti-synaptobrevin 2 im- 
munobeads to deplete almost completely synaptobrevin 1 
and ceUubrevin from the PC12 cell extract demonstrates that 
nearly all vesicles positive for synaptobrevin 2 are also posi- 
tive for synaptobrevin 1 and ceUubrevin. Thus, the three pro- 
teins do not colocalize only on sorting compartments such as 
endosomes, but in most organelles. This result conclusively 
establishes that synaptobrevin 1 and 2 and cellubrevin are 
colocalized on the same vesicles. The mitochondrial ATPase 
remained in the supernatants confirming the specificity of 
the immunoisolation procedure (Fig. 9). All these proteins 
were recovered in the supernatants of the non-immune IgG 
beads.  The complete immunoisolation of secretogranin 2 
contrasts with the low amount of synaptobrevin and cellu- 
brevin observed in the dense-core granule containing frac- 
tions of sucrose density gradients (Fig. 9). Electron micros- 
copy analysis showed that in addition to a large number of 
pleomorphic vesicles, dense-core granules were also pres- 
ent on the synaptobrevin 2  immunobeads (Fig.  10).  While 
the bulk of synaptophysin and synaptobrevin/cellubrevin is 
clearly localized on light vesicles, a small amount of these 
proteins present in the membranes of the granules may be 
sufficient to allow their immunoisolation. 
It has been reported that TeTx-LC inhibits catecholamine 
release  from  dense-core  vesicles  in  SLO-permeabilized 
PC12 cells (Ahnert-Hilger et al.,  1989; Ahnert-Hilger and 
WeUer,  1993).  Our  results indicating the presence of the 
Figure 8.  Distribution of secretory vesicle markers from a low-speed supernatant of PC12 cell homogenate by isopycnic centrifugation 
on a 0.4-2 M sucrose gradient. Equal volumes of gradient fractions were analyzed by SDS-PAGE and Western blotting for the proteins 
indicated. 
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2-containing  organeUes. A  high-speed postnuclear  supernatant 
from PC12 cells was incubated with anti-synaptophysin, anti-syn- 
aptobrevin 2,  or control mouse IgG metaerylate immunobeads. 
Equal volume of the starting material (SM), the supernatants (S), 
or the bead pellets (P) were analyzed by SDS-PAGE and Western 
blotting for their content in secretogranin 2, Tf receptor, synap- 
totagmin 1, synaptophysin, mitochondrial ATPase, synaptobrevin 
1, synaptobrevin 2, and cellubrevin. 
three v-SNAREs of the synaptobrevin family in the mem- 
branes of dense-core granules  (Fig.  10),  supports the hy- 
pothesis that this inhibitory effect may be mediated by cleav- 
age  of these  proteins.  We  investigated  therefore whether 
inhibition of catecholamine release correlates with a parallel 
cleavage of the three proteins. As shown in Fig. 10, TeTx-LC 
produced a strong inhibition of Ca2+-evoked [3H]NE release 
('~50%) which was already maximal at 5 min. It also pro- 
duced a  massive,  although  not complete,  cleavage of the 
three proteins which was also already maximal at 5 min (Fig. 
11). The close temporal correlation between the two effects 
strongly supports a direct relationship between proteolysis of 
the  synaptobrevins  and  cellubrevin and  the  inhibition  of 
secretion. Note that TeTx-LC cleaved not only synaptobrevin 
2  and cellubrevin, but also  synaptobrevin 1.  Although rat 
synaptobrevin 1 is more resistant to the proteolytic action of 
this toxin than synaptobrevin 2, cleavage of synaptobrevin 1 
by TeTx in synaptic vesicles was previously reported (Schiavo 
et al.,  1993; Yamasaki et al.,  1994). In our experiments, no 
unspecific proteolysis mediated by 300 nM TeTx-LC of syn- 
aptic  vesicle proteins  other than  synaptobrevins and  cel- 
lubrevin was observed (not shown). The inhibition of Ca  2+- 
evoked catecholamine secretion from PC12 cells produced 
by TeTx was only about 50% in spite of the nearly complete 
Figure 10. Electron micrographs illustrating organelles which bind 
to anti-synaptobrevin 2 immunobeads. Small pleomorphic vesicles 
as well as dense-core granules are visible on the anti-synaptobrevin 
2  immunobeads. Electron-dense  filamentous material  is  repre- 
sented by the agarose used for bead embedding. The inset shows 
lack of organelle binding to immunobeads conjugated to control 
mouse IgGs. Bar, 400 nm. 
cleavage of synaptobrevins and cellubrevin. Similar incom- 
plete inhibition of secretion in spite of massive cleavage of 
these proteins of the synaptobrevin/cellubrevin family was 
observed in other systems (Galli et al., 1994; Gaisano et al., 
1994). These findings suggest the possible existence of other 
v-SNAREs more substantially divergent from synaptobrevin 
1 and 2 and cellubrevin. 
Synaptobrevin 1 and 2 were previously shown to interact 
with the neuronal t-SNAREs syntaxin I and SNAP25. To fur- 
ther prove that cellubrevin and the two synaptobrevins are 
functionally similar,  we  investigated  whether  cellubrevin 
forms a  complex with the same two t-SNAREs which are 
both expressed in PCI2 cells. Triton X-100 extracts of PC12 
cells  postnuclear  supernatants  were  immunoprecipitated 
with antibodies directed against synaptobrevin 2, syntaxin or 
SNAP25.  As shown by Fig.  12,  anti-syntaxin  1 and anti- 
SNAP25  antibodies  coprecipitated  not  only  the  partner 
t-SNARE and  synaptobrevin 2,  but also cellubrevin. The 
specificity of the immunoprecipitations was indicated by the 
absence of synaptotagmin in all pellets and by the absence 
of  cellubrevin  in  the  immunoisolation  performed  with 
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Figure  II.  TeTx-LC mediated  inhibition of [3H]norepinephrine 
(NE) release and cleavage of synaptobrevin/cellubrevin in SLO- 
permeabilized  PCI2  cells.  (Top) Fractional  release  of [3H]NE 
from  cells  pre-loaded  with  the  radiolabeled  compound.  The 
amount of [3H]NE  released in each sample is expressed as the per- 
centage of the total [3H]NE  present in that sample (cell-associated 
plus released [3H]NE). For each time point and treatment, values 
represent the mean + SD of three determinations from a represen- 
tative experiment. (Bottom) Synaptobrevin I and 2 and cellubrevin 
content (as determined by Western blotting) of cells used for the 
determination of [3H]NE release in the absence of Ca  2+. Similar 
cleavage by 300 nM TeTX-LC of synaptobrevin 1 and 2 and cel- 
lubrevin was observed in the presence of 100 nM free Ca  2+ (not 
shown). 
anti-synaptobrevin  2  immunobeads.  No  v-  or  t-SNARE 
were precipitated by non-immune IgGs (not shown). 
Discussion 
A large body of experimental evidence has indicated that the 
fundamental mechanisms of exocytosis are very similar in 
all cells (Aalto et al.,  1992;  Bennett and Scheller,  1993; 
Ferro-Novick  and Jahn, 1994). However, it is clear that addi- 
tional features must be superimposed on these general mech- 
l~igure  12.  Immunoprecipita- 
don of the SNARE complex. 
Triton X-100  extract of PCl2 
cells was immunoprecipitated 
with  antibodies  directed 
against synaptobrevin 2  (A), 
syntaxin 1 (B), or SNAP-25 
(C). 1/10  of the starting mate- 
rial  (SM),  or  bead  pellets 
(A-C) were analyzed by SDS- 
PAGE and Western  blotting for 
their content in synaptotagmin 
1, syntaxin 1, SNAP-25, syn- 
aptobrevin 2, and cellnhrevin. 
Cellubrevin forms complexes 
with syntaxin 1 and SNAP-25. 
anisms  to  account  for  specific properties  of distinct  ex- 
ocytotic vesicles within the same cell. Synaptobrevin 1 and 
2 are v-SNAREs which are primarily expressed in the brain 
where they are concentrated in synaptic vesicles. These or- 
ganelles, whose exocytosis is highly regulated, are thought 
to  be  a  specialized  form  of  endosome-derived  vesicles 
(Cameron et  al.,  1991;  Linstedt  and  Kelly,  1991).  Cel- 
lubrevin, a member of the synaptobrevin family, is expressed 
in a wide variety of tissues and was reported to be localized 
on endosome-derived, Tf receptor-containing vesicles which 
undergo exocytosis constitutively (McMahon et al.,  1993; 
Galli et al., 1994). These findings have raised the possibility 
that the distinct patterns of cellular expression of the three 
proteins could be related to the property of the two synap- 
tobrevins and cellubrevin to function in distinct secretory 
pathways. We show here that, when co-expressed physiologi- 
cally in the same cell, the three proteins have a similar sub- 
cellular distribution  and  interact with  the  same  neuronal 
t-SNAREs.  These  results  speak  against  functional differ- 
ences between synaptobrevin 1,  synaptobrevin 2  and  cel- 
lubrevin related to distinct types of exocytotic vesicles. 
To demonstrate whether cellubrevin can be targeted to- 
gether with  synaptobrevins to  synaptic  vesicles,  we have 
taken advantage of the property of PC12 cells to express all 
three proteins at relatively high levels. This is in contrast to 
the pattern of expression of  the three proteins in brain, where 
cellubrevin is primarily localized in non-neuronal cells and 
is virtually undetectable in neurons. PC12 cells, like other 
peptide secreting endocrine cells and cell lines,  contain a 
population  of small  vesicles,  synaptic-like  microvesicles, 
which are the functional and structural equivalent of synaptic 
vesicles of  neurons (Navone et al., 1986; Wiedenmann et al., 
1988; Cameron et al.,  1991; Reetz et al.,  1991).  Like neu- 
ronal synaptic vesicles, synaptic-like microvesicles exclude 
typical markers of constitutive endosome-derived vesicles 
such as Tf receptors and LDL receptors (Cameron et al., 
1991;  Linstedt and  Kelly,  1991).  Furthermore,  endocrine 
synaptic-like microvesicles are enriched in the neurites that 
PC12 cells extend after NGF-induced differentiation (Tisch- 
ler and Greene, 1978). These processes have several other 
axonal characteristics including the property to exclude Tf 
receptor (this study) and the G protein of the vesicular sto- 
matitis virus (Rivas and Moore, 1989), two proteins which, 
in neurons, are selectively targeted to dendrites (Cameron 
et  al.,  1991;  Dotti  and  Simons,  1990).  Using  immuno- 
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strated that cellubrevin and the synaptobrevins have a very 
similar  subceUular  distribution  in  PC12  cells  and  are 
colocalized  on  synaptic-like  microvesicles:  they  are  co- 
enriched in neurites, are primarily localized in light fractions 
of  sucrose  density  gradient  which  contain  synaptic-like 
microvesicles (Cameron et al., 1990, and are detectable in 
the synaptic-like microvesicle peak in glycerol velocity gra- 
dients. This peak is completely devoid of Tf receptor (this 
study and Cameron et al., 1991). Thus, cellubrevin does not 
appear to be a specialized v-SNARE for constitutive recy- 
cling Tf receptor containing vesicles. 
While the vast majority of the synaptobrevin/cellubrevin 
molecules in PC12 cells are localized on organelles of low 
buoyant density, our data are also consistent with a colocal- 
ization of a small pool of the three v-SNAREs in the mem- 
brane of dense-core secretory granules which store and se- 
crete  peptides  and  amines  (Bauerfeind et  al.,  1993).  In 
previous studies, synaptobrevin immunoreactivity on dense- 
core granules of neurons and endocrine cells had not been 
demonstrated (Baumert et al.,  1989;  Thomas-Reetz et al., 
1993). This finding appeared at odds with the demonstration 
that TeTx-LC inhibits catecholamine secretion from PC12 
cells (Ahnert-Hilger and Weller,  1993).  As shown in this 
study, TeTx-mediated cleavage of synaptobrevin/cellubrevin 
correlates with an impairment of exocytosis of dense-core 
granules. Thus, although only a small pool of synaptobrevin 
is localized in the granule fraction, all granule membranes 
must contain at least a few synaptobrevin/cellubrevin mole- 
cules. The existence of at least low levels of these proteins 
on the membrane of dense core vesicles is suggested by two 
independent lines of investigation. First, immunoisolation 
experiments with anti-synaptobrevin 2  antibodies demon- 
strated that dense-core granules can be quantitatively recov- 
ered in the bead fraction. Second, in sucrose density gra- 
dients a  trail of the synaptobrevin/cellubrevin peaks were 
observed in regions of high buoyant density which contain 
secretory granules. When a low-speed supernatant of bovine 
chromaflin cells, which contains a greater amount of secre- 
tory granules, was separated in the same type of gradients, 
the relative proportion of synaptobrevin found in the dense- 
granules fraction was greater than in PC12 cells (our unpub- 
lished observations). 
It appears therefore that synaptobrevin 1 and 2 and cel- 
lubrevin  share  a  similar function and may be  present in 
different combinations on the same vesicular carriers as was 
previously shown for other synaptic vesicle-associated pro- 
teins (Sudhof et al., 1989; Geppert et al., 1991; Fykse et al., 
1993; Bajjalieh et al., 1993). Isoform specific characteristics 
may contribute to the fine tuning of  the function of  exocytotic 
carriers but do not appear to contribute major functional 
differences. This is in agreement with studies performed in 
yeast. At least two synaptobrevin isoforms were detected on 
yeast secretory vesicles but they appear to have a  similar 
function since one of the two is sufficient to sustain exocyto- 
sis and growth (Protopopov et al.,  1993).  Whether synap- 
tobrevins and cellubrevin play a role also in the exocytosis 
of constitutive, Golgi-derived vesicles which deliver synap- 
tic vesicle precursor membrane to the cell surface (Regnier- 
Vigouroux et al.,  1991) remains to be elucidated by future 
studies. 
If synaptobrevins and cellubrevin have similar functions in 
exocytosis, can synaptobrevin 1 and 2 be localized on consti- 
tutive recycling vesicles in non-neuronal ceils and neuronal 
cells? The expression of low levels of synaptobrevins in cells 
lacking classical Ca:÷-dependent exocytosis such as muscle 
cells (Ralston et al.,  1994),  and adipocytes (Cain et al., 
1992) supports this possibility. Furthermore, significant lev- 
els of synaptobrevin immunoreactivity are present in the 
perikaryal dendritic region of immature neurons in culture 
(Mundigl et al.,  1993).  As neurons mature and form syn- 
apses, synaptobrevin immunoreactivity in dendrites falls to 
almost undetectable levels,  but this change may reflect a 
down regulation of constitutive recycling at the cell surface 
of dendrites (Mundigl et al.,  1993).  For example, clathrin 
and dynamin immunoreactivity are present only at very low 
levels in dendrites of most adult neurons (Maycox et al., 
1992;  McPherson et al.,  1994;  Takei et al.,  1995). 
Our previous demonstration that cellubrevin is required 
for exocytosis in cells which do not express the neuronal 
t-SNAREs (SNAP25 and syntaxin 1) (Galli et al., 1994), im- 
plies that cellubrevin must interact with non-neuronal plas- 
malemma t-SNAREs  (Oyler et al.,  1991; Bennett et al., 
1993). However, we have shown here that cellubrevin can in- 
teract with  syntaxin  1 and SNAP25,  further proving the 
functional similarity of synaptobrevin 1, 2 and cellubrevin. 
In  conclusion,  our  data  suggest  that  cellubrevin,  synap- 
tobrevin t and synaptobrevin 2 do not play specialized roles 
in constitutive and regulated secretion, respectively, and are 
not involved in determining the spatial and temporal spec- 
ificity of exocytotic reaction of different secretory pathways. 
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